Literature DB >> 28911901

Structural Brain Abnormalities of Attention-Deficit/Hyperactivity Disorder With Oppositional Defiant Disorder.

Siri D S Noordermeer1, Marjolein Luman2, Corina U Greven3, Kim Veroude4, Stephen V Faraone5, Catharina A Hartman6, Pieter J Hoekstra6, Barbara Franke7, Jan K Buitelaar8, Dirk J Heslenfeld2, Jaap Oosterlaan2.   

Abstract

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is associated with structural abnormalities in total gray matter, basal ganglia, and cerebellum. Findings of structural abnormalities in frontal and temporal lobes, amygdala, and insula are less consistent. Remarkably, the impact of comorbid oppositional defiant disorder (ODD) (comorbidity rates up to 60%) on these neuroanatomical differences is scarcely studied, while ODD (in combination with conduct disorder) has been associated with structural abnormalities of the frontal lobe, amygdala, and insula. The aim of this study was to investigate the effect of comorbid ODD on cerebral volume and cortical thickness in ADHD.
METHODS: Three groups, 16 ± 3.5 years of age (mean ± SD; range 7-29 years), were studied on volumetric and cortical thickness characteristics using structural magnetic resonance imaging (surface-based morphometry): ADHD+ODD (n = 67), ADHD-only (n = 243), and control subjects (n = 233). Analyses included the moderators age, gender, IQ, and scan site.
RESULTS: ADHD+ODD and ADHD-only showed volumetric reductions in total gray matter and (mainly) frontal brain areas. Stepwise volumetric reductions (ADHD+ODD < ADHD-only < control subjects) were found for mainly frontal regions, and ADHD+ODD was uniquely associated with reductions in several structures (e.g., the precuneus). In general, findings remained significant after accounting for ADHD symptom severity. There were no group differences in cortical thickness. Exploratory voxelwise analyses showed no group differences.
CONCLUSIONS: ADHD+ODD and ADHD-only were associated with volumetric reductions in brain areas crucial for attention, (working) memory, and decision-making. Volumetric reductions of frontal lobes were largest in the ADHD+ODD group, possibly underlying observed larger impairments in neurocognitive functions. Previously reported striatal abnormalities in ADHD may be caused by comorbid conduct disorder rather than ODD.
Copyright © 2017 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; Comorbidity; Cortical thickness; ODD; SBM; Structural MRI

Mesh:

Year:  2017        PMID: 28911901     DOI: 10.1016/j.biopsych.2017.07.008

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

1.  Disrupted brain functional networks in drug-naïve children with attention deficit hyperactivity disorder assessed using graph theory analysis.

Authors:  Ying Chen; Xiaoqi Huang; Min Wu; Kaiming Li; Xinyu Hu; Ping Jiang; Lizhou Chen; Ning He; Jing Dai; Song Wang; Manxi He; Lanting Guo; John A Sweeney; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2019-07-30       Impact factor: 5.038

2.  Comparing GWAS and Brain Structure-Specific Gene Expression Profiles Identifies Psychiatric Disorder-Related Brain Structures at Different Developmental Stages.

Authors:  Xin Qi; Cuiyan Wu; Yanan Du; Shiqiang Cheng; Yan Wen; Mei Ma; Chujun Liang; Li Liu; Bolun Cheng; Lu Zhang; Ping Li; Feng Zhang
Journal:  Neurosci Bull       Date:  2020-05-30       Impact factor: 5.203

3.  Shifting Focus: From Group Patterns to Individual Neurobiological Differences in Attention-Deficit/Hyperactivity Disorder.

Authors:  Alison E Lenet
Journal:  Biol Psychiatry       Date:  2017-11-01       Impact factor: 13.382

4.  Anatomical substrates of symptom remission and persistence in young adults with childhood attention deficit/hyperactivity disorder.

Authors:  Yuyang Luo; Jeffrey M Halperin; Xiaobo Li
Journal:  Eur Neuropsychopharmacol       Date:  2020-02-17       Impact factor: 4.600

Review 5.  The associations of comorbid substance use disorders and psychiatric conditions with adolescent brain structure and function: A review.

Authors:  Danielle S Kroll; Dana E Feldman; Szu-Yung Ariel Wang; Rui Zhang; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  J Neurol Sci       Date:  2020-08-19       Impact factor: 3.181

6.  Increased Temporal Lobe Beta Activity in Boys With Attention-Deficit Hyperactivity Disorder by LORETA Analysis.

Authors:  Ching-Tai Chiang; Chen-Sen Ouyang; Rei-Cheng Yang; Rong-Ching Wu; Lung-Chang Lin
Journal:  Front Behav Neurosci       Date:  2020-06-30       Impact factor: 3.558

Review 7.  The Therapeutic Effect of the Chinese Herbal Medicine, Rehmanniae Radix Preparata, in Attention Deficit Hyperactivity Disorder via Reversal of Structural Abnormalities in the Cortex.

Authors:  Haixia Yuan; Meng Yang; Xinmin Han; Xinqiang Ni
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-14       Impact factor: 2.629

8.  Neural cell adhesion molecule Negr1 deficiency in mouse results in structural brain endophenotypes and behavioral deviations related to psychiatric disorders.

Authors:  Katyayani Singh; Mohan Jayaram; Maria Kaare; Este Leidmaa; Toomas Jagomäe; Indrek Heinla; Miriam A Hickey; Allen Kaasik; Michael K Schäfer; Jürgen Innos; Kersti Lilleväli; Mari-Anne Philips; Eero Vasar
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

9.  Peripheral Brain-Derived Neurotrophic Factor and Contactin-1 Levels in Patients with Attention-Deficit/Hyperactivity Disorder.

Authors:  Liang-Jen Wang; Chih-Ching Wu; Min-Jing Lee; Miao-Chun Chou; Sheng-Yu Lee; Wen-Jiun Chou
Journal:  J Clin Med       Date:  2019-09-02       Impact factor: 4.241

10.  Structural brain alterations and their association with cognitive function and symptoms in Attention-deficit/Hyperactivity Disorder families.

Authors:  Wenhao Jiang; Kuaikuai Duan; Kelly Rootes-Murdy; Pieter J Hoekstra; Catharina A Hartman; Jaap Oosterlaan; Dirk Heslenfeld; Barbara Franke; Jan Buitelaar; Alejandro Arias-Vasquez; Jingyu Liu; Jessica A Turner
Journal:  Neuroimage Clin       Date:  2020-04-23       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.